Unveiling 6 Analyst Insights On Kymera Therapeutics
Unveiling 6 Analyst Insights On Kymera Therapeutics
揭示Kymera Therapeutics的6個分析師見解
The...Providing a diverse range of perspectives from bullish to bearish, 6 analysts have published ratings on Kymera Therapeutics (NASDAQ:KYMR) in the last three months.
在過去三個月中，有6位分析師公佈了對Kymera Therapeutics（納斯達克股票代碼：KYMR）的評級，提供了從看漲到看跌的不同視角。
The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.
下表彙總了他們最近的評級，闡明瞭過去30天內情緒的變化，並將其與前幾個月進行了比較。
Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $44.0, along with a high estimate of $52.00 and a low estimate of $36.00. This upward trend is apparent, with the current average reflecting a 5.19% increase from the previous average price target of $41.83.
分析師提供了更深入的見解，確定了12個月的目標股價，平均目標價爲44.0美元，最高估計爲52.00美元，低估值爲36.00美元。這種上升趨勢顯而易見，當前的平均價格較之前的平均目標價41.83美元上漲了5.19％。
Breaking Down Analyst Ratings: A Detailed Examination
分解分析師評級：詳細審查
The...
對...
登入免費觀看全文
登入/註冊
資訊熱榜
更新時間